Aims/hypothesis. Type I (insulin-dependent) diabetes mellitus results from an immune-mediated destruction of pancreatic beta cells for which HLA haplotypes DR3-DQ2 and DR4-DQ8 represent the strongest genetic risk markers. Mothers of patients with rheumatoid arthritis carry more frequently the HLA DR4-DQ8 haplotype as non-transmitted haplotype than mothers of healthy control subjects. As maternal cells have been shown to persist in their offspring up to 30 years after birth, we investigated whether the association of HLA DR3-DQ2 and DR4-DQ8 with Type I diabetes is purely a genetic effect acting through inheritance or whether it can also act as an environmental factor, for example through foetal exposure in utero to maternal circulating cells. Methods. We analysed the non-transmitted parental HLA DQ alleles of 464 families (1367 subjects) with a Type I diabetic offspring. HLA DQ alleles were assessed using sequence-specific primers and allele-specific oligonucleotides hybridisation. A chi-square test was done to compare allele and transmission frequencies in the respective subsets of families.
particular epitopes of HLA DR-DQ haplotypes fully explain this strong association or whether linked genes play a role is not resolved because at least one non-HLA gene on chromosome 6p is involved in susceptibility [2] . HLA DR and -DQ genes encode antigen-presenting molecules that initiate T-lymphocyte proliferation after having bound "foreign" peptides. Tlymphocytes are the key elements of the insulitis leading to selective beta-cell loss -a process that can occur as early as during embryonic-foetal development [3] .
Several groups have accumulated much evidence showing that HLA DR4-DQ8 and DR3-DQ2 represent the main predisposing haplotypes [4, 5] . This Type I (insulin-dependent) diabetes mellitus results from an immune-mediated destruction of pancreatic beta cells with strongest susceptibility conferred by HLA region genes identified in 1974 [1] . Whether was shown by both case-control and family studies, in which haplotype distributions of patients were compared with the non-transmitted haplotypes of their parents or with the haplotype frequencies of unrelated control subjects. To elucidate the parental origin of diabetogenic risk alleles we examined whether in Type I diabetic offspring the frequencies of maternal differ from paternal non-transmitted HLA DQ alleles.
Subjects and methods
The study was carried out in accordance with the declaration of Helsinki. Families of Caucasian origin were recruited at the diabetic outpatient clinic at the University Hospital Frankfurt am Main, Germany, and by the Belgian Diabetes Registry (206 trios) and informed consent was obtained. Altogether, we studied 1367 subjects (464 offspring affected with Type I diabetes that were derived from 439 complete pedigrees and 25 mother-child pairs). All parents were non-diabetic. HLA DQ alleles had been assigned by standard methods using sequence-specific primers [6] for the German and allele-specific oligonucleotide (ASO) hybridization for the Belgian families [7] . HLA DQ2 (DQA1*0501-DQB1*0201) and HLA DQ8 (DQA1*0301-DQB1*0302) were considered as high risk alleles. Preferential transmission to all 464 affected offspring was detected by transmission disequilibrium testing (TDT) [8] , which compares the observed transmission frequencies by heterozygous parents with the expected frequency of 50%. The families were assigned to subsets according to the offsprings' HLA DQ genotype: DQ2/DQ8 heterozygous -a; DQ2 and DQ8 homozygous -b; genotype DQ2/x or DQ8/x -c; genotype DQx/x -d (x: not D2 or DQ8). The analyses were done for HLA DQ2 and DQ8 combined. For subsets b and c both risk alleles were also considered individually. Chi-square testing with Yates' correction was applied to compare the frequencies of maternal and paternal non-transmitted HLA DQ alleles excluding the 25 mother-child pairs. A p value of less than 0.05 was considered significant.
Results
Transmission of HLA DQ2 and DQ8. Both, HLA DQ2 (264 t vs 100 nt; p=8.3×10 -18 ) and HLA DQ8 (276 t vs 66 nt; p=7.0×10 -30 ) were preferentially transmitted to Type I diabetic offspring (Table 1) .
Non-transmitted HLA DQ2 and DQ8 alleles -all patients.
Considering all affected offspring, the nontransmitted DQ8 allele was more abundant (p<0.04) in mothers (13.6%) than in fathers (8.9%). We then wondered whether this observation might have been due to differences in the proportion of DQ2/DQ8 heterozygous mothers or fathers. However, only 41 of 464 (8.8%) mothers and 32 of 439 fathers (7.3%) were typed DQ2/DQ8 and transmission frequencies of DQ8 did not differ between mothers (46.3%) and fathers (40.6%), thus not accounting for the differences in non-transmission rates.
Non-transmitted HLA DQ2 and DQ8 alleles -subset analyses. Subsequently we compared maternal and paternal non-transmitted HLA DQ alleles in the subsets stratified for the offsprings' HLA DQ genotype. Considering the 143 DQ2/DQ8 heterozygous offspring (group a; Table 2 ) the frequencies of maternal and paternal non-transmitted HLA DQ2 and DQ8 did not differ (p=0.3144). However, mothers of the 63 HLA DQ2 and DQ8 homozygous children (group b) were more often carriers of a non-transmitted HLA DQ2 or DQ8 than fathers (34.9% vs 17.5% -p=0.0427). Similarly, a maternal non-transmitted HLA DQ high risk haplotype (40.2%) was more frequent than a paternal one (27.6%) in the subset of those 174 patients with genotype DQ2/x and DQ8/x (p=0.0343). Only 59 patients did not inherit a susceptibility allele from either parent, of which 18 mothers (12 DQ2, 6 DQ8) but only 7 fathers (6 DQ2, 1 DQ8) carried a non-transmitted diabetogenic risk allele (p=0.0243).
As heterozygosity for DR3-DQ2/DR4-DQ8 confers the highest risk for Type I diabetes, we investigated whether DQ2 and DQ8 homozygous patients (group b) and those with either risk allele alone (group c) might have encountered a complementary non-inherited susceptibility combination through their mothers. Although 14.3% of the mothers of HLA DQ2 and DQ8 homozy- Altogether, a high risk HLA DQ allele was present in either transmitted or maternally non-transmitted form in 420 (90.5%) of all the patients studied.
Discussion
Although the inherited susceptibility to Type I diabetes are conferred by HLA DR-DQ genes, the largest proportion of patients suffers from a sporadic disease. We therefore focused on whether such genetic factors differ in mothers of patients from those present in fathers. We show that mothers of Type I diabetic patients, except those who are DQ2/DQ8 heterozygous, carry significantly more often HLA DQ2 or DQ8 as non-transmitted allele than fathers. However, there was no such difference in those families with a DQ2/DQ8 heterozygous offspring. Mothers of patients with Type I diabetes had been reported to have less non-transmitted HLA DR-DQ high risk alleles than parents of healthy children [9] . HLA DR4-DQ8 is more frequent as maternal non-transmitted haplotype in patients with rheumatoid arthritis than in control subjects. This observation can be explained by a non-genetic effect of DR4-DQ8 on the formation of the T-cell repertoire [10] . These non-inherited maternal HLA antigens have also been implicated in the tolerance of organ transplants [11] . The patient's exposure to the maternal non-inherited HLA DR-DQ haplotype could contribute to disease susceptibility by a yet unknown mechanism. If non-transmitted HLA DQ alleles increase the risk for Type I diabetes by complementing the patient's genetic risk, a functional mechanism must be involved in which either two different HLA molecules present the antigenic peptide better than one or two antigen receptors increase the likelihood of a pathogenic process leading to beta-cell autoimmunity. This could either happen in utero or post partum. Several studies have shown that maternal cells persist in their children and can be found in the offspring's peripheral blood, lymph nodes and other tissues up to 30 years post partum. Such 'microchimerism' has been shown to be more common in the autoimmune diseases systemic sclerosis, Sjögren's syndrome, and primary biliary cirrhosis [12, 13] . Persistent maternal microchimerism has been described in juvenile myopathy [14] and was recently reported to occur more frequently in patients than in healthy control subjects [15] . Such microchimerism has been found to be associated with HLA DR3-DQ2 and can increase the risk for an autoimmune disease both in the mother and the infant depending on the HLA DR-DQ compatibility in either direction. Persisting foetal cells were found in the thyroid tissues of mothers with Graves' disease [16] and some evidence suggests that these cells are more frequent in mothers with thyroid disorders compared to subjects with clinically and histologically normal thyroids [17] . Although microchimerism has so far not been reported for Type I diabetes, our observations are compatible with maternal microchimerism contributing to Type I diabetes susceptibility. DR3-DQ2/DR4-DQ8 heterozygosity confers an excess risk to Type I diabetes that is not explained by the individual haplotypes. This heterozygous state can extend to subjects harbouring microchimers with the complementary HLA DQ allele. Thus maternal cells carrying high risk HLA DR-DQ haplotypes would persist in the child's circulation or lymph node ready to present antigenic peptides to T-lymphocytes. In this case, the destruction of beta cells could result from a graft versus host reaction rather than from a true autoimmune process. Whether persisting maternal immunogenic cells could also help to shape the thymic repertoire, has yet to be elucidated.
In conclusion, we have detected an additional susceptibility factor for Type I diabetes that is conferred by mothers through non-transmitted HLA DQ2 and DQ8 alleles. Thus these antigen presenting molecules are not only genetic but also environmental factors that are present in either constellation in 91% of patients. These results contribute to the understanding of the HLA association with Type I diabetes. Structural features of HLA DQ such as the P9 pocket and its functional sequelae on binding of immunodominant peptides of proteins such as insulin [18] should direct further research to predict and prevent Type I diabetes. It remains to be elucidated by which mechanism the intrauterine exposure to maternal HLA molecules or the persistence of maternal cells (microchimerism) could influence the offspring's susceptibility to Type I diabetes.
